Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Onvatilimab
Trade Name
Synonyms CI 8993|CI8993|CI-8993|JNJ 61610588|JNJ61610588|JNJ-61610588
Drug Descriptions

Onvatilimab (CI-8993) is a monoclonal antibody that targets and binds to VSIR (VISTA; PD-1H) on immune cells leading to decreased VSIR-mediated signaling and potentially resulting in activation of anti-tumor immune response and inhibition of tumor cell growth (NCI Drug Dictionary).

DrugClasses VSIR Antibody 6
CAS Registry Number NA
NCIT ID C177901

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Onvatilimab Onvatilimab 0 2


Additional content available in CKB BOOST